Study design: Systematic review.
Systematic review-Surgical versus injection treatment for injection-confirmed chronic sacroiliac joint pain

RESULTS
• From a total of 303 citations retrieved, 32 were evaluated for full-text review, and twelve met the inclusion criteria (Fig 1) . A diagnosis of sacroiliac joint pain was confirmed by injection in all studies.
• Seven case series (CoE IV) evaluated surgery (fusion or debridement) for chronic sacloiliac joint pain [2] [3] [4] [5] [6] [7] [8] .
Five studies evaluated injection therapy for sacroiliac joint pain using corticosteroid, Botulinum toxin, or prolotherapy [9] [10] [11] [12] [13] . Three of the injection studies were comparative studies; however, these are considered case series (CoE IV) for this review, with each treatment arm considered separately [9, 11, 12] .
• Since no studies comparing surgery with injection therapy in the same population were identified, conclusions from direct treatment comparisons are not possible. Populations in included studies were predominantly female and middle-aged ( Table 1) .
Further details on the class of evidence rating for these studies can be found in the supplemental Web Appendix at www.aospine.org/ebsj. Although these studies were designed to compare injection treatments, for the purpose of this review they are considered case series, with each arm addressed separately, since the study question focuses on comparing surgery with injection [9, 11, 12] . † Demographics applicable to patients analyzed [11] ; patients completing all discharge questionnaires [13] ; and patients before diagnostic block performed (n = 118 patients had positive diagnostic block and were included in study) [10] . Study also included 42 patients who received a lumbar facet joint injection and 10 patients who received a medial branch block [9] . Pain (Fig 2 and Web Appendix)
• All eight studies evaluating pain reported improvement regardless of the treatment, with most studies reporting over 40% improvement in pain as measured by VAS or NRS score [2, 4, [11] [12] [13] . Two studies described minimal clinically important differences (MCID) [2, 12] . Based on indirect comparison of surgical and injection studies, improvement from baseline pain was similar for both treatment options.
• Four of the seven surgical studies [4] reported on pain, with debridement patients showing greater pain improvement than fusion patients [2] . One study [6] reported only 3 patients (17.6%) experiencing mild/no pain compared with 14 patients (82.4%) experiencing marked/severe pain at 39 months.
• Of four injection studies reporting on pain, most patients receiving Botulinum toxin injection [12] or prolotherapy [11] experienced greater pain relief than patients receiving corticosteroid therapy [11] [12] [13] . One study [10] found that 78 (66.1%) of 118 patients required two or more injections to achieve at least 50% pain relief for 2 or more weeks.
• Al-Khayer et al [2] defined the MCID for VAS as a 2-point score change, with 9 (100%) of 9 fusion patients achieving the MCID. Another study [12] defined the MCID for NRS as a 50% reduction in score, reporting that 88% of patients receiving Botulinum toxin injection exceeded the MCID. Functional and quality-of-life outcomes (Table 2 and Fig 3) • The four surgical and two injection studies evaluating functional outcomes reported improvement as measured by ODI, AAOS/MODEMS, or the Majeed score regardless of the treatment, with most studies reporting over 20% improvement in functionality. Conclusions regarding the comparative effectiveness of surgical treatment versus injection are not possible.
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• One debridement study [4] reported that 23 (60%) of 38 patients experienced an improved ODI score, with only 1 (2%) of 38 experiencing increased impairment at over 2 years' follow-up (details NR).
• In several injection studies, patients receiving a Botulinum toxin injection or prolotherapy experienced over 50% improvement in ODI scores [11, 12] . Studies using corticosteroid injections exhibited inconsistent results [11] [12] [13] .
• Al-Khayer et al [2] defined the MCID for ODI as a 10% change, with 8 (88.9%) of 9 fusion patients achieving MCID. Another study defined the MCID for ODI as a 40% reduction in score and reported that 88% of patients receiving Botulinum toxin injection exceeded the MCID [12] .
• Two surgical fusion studies evaluating health-related quality of life reported improvement measured by the SF-36 [3, 5] . Results for mean improvement in SF-36 Physical Component Summary were inconsistent. [Buchowski, Khurana] . Transformed scores reported; transformation not defined [Buchowski] .
Fusion (surgical studies only)
• Four studies reported fusion rates ranging from 85%-100% at follow-ups covering 6-40 months [2, 3, 5, 8] and one fusion study [6] reported that 58.8% of patients experienced definite/questionable fusion. Fusion was determined by radiographs alone in two studies [2, 3] , mixed radiographs, and CT scans in one study [6] , radiographs for all and additional CT scans on symptomatic patients in one study [5] , and CT scans for all patients in one study [8] . Scant details were provided in a few studies regarding the criteria for determining successful fusion, including absence of clinical symptoms and absence of radiological signs of metal failure or lucency [5] , bone fusion of sacroiliac joint visible on CT scan [6] , and absence of loosening around cages and evidence of bone bridging through the cage from the sacrum to the ileum [8] .
Return to work
• One fusion study reported that 4 (44.4%) of 9 patients had returned to work at 40-month follow-up [2] , with another fusion study reporting 8 (40%) of 20 patients returning to work at the 5.8-year follow-up (mean: 5.0 ± 1.6 month-time to return to work) [3] .
• One injection study reported that no patients experienced a worsened work status, 13 (54.2%) of 24 reported an unchanged work status, and 11 (45.8%) of 24 reported an improved work status at a mean of 23.6-month follow-up [13] .
Complications
• Five surgical studies reported complications [2, 3, [6] [7] [8] . Infection rates varied from 4.8%-11.1% (mean follow-up of 30 months to 5.8 years) [2, 3, 7] . Nonunion occurred in 7.7%-41.2% of patients in four surgical studies (mean follow-up of 29.5 months to 5.8 years) [3, [6] [7] [8] . Further surgery was reported in two surgical studies for hardware removal, scar tissue excision, and a second fusion: 1 (5%) of 20 patients (5.8-year follow-up) [3] and 11 (64.7%) of 17 patients (39-month follow-up) [6] ). An intraoperative fracture was reported in 1 (5.9%) of 17 patients [6] .
• One injection study reported flu-like symptoms in 2 (10%) of 20 patients receiving Botulinum toxin [12] .
CLINICAL GUIDELINES
• Numerous guidelines were found addressing sacroiliac joint pain or low back pain; however, few address the use of surgery for relief of CSJP: • The Work Loss Data Institute recommended sacroiliac joint block/injections [14, 15] , has sacroiliac joint debridement under study [14] , and did not recommend sacroiliac joint fusion or radiofrequency neurotomy [14] for work-related injuries [14] and work-related low back pain [15] .
• A practice guideline for chronic pain management recommended sacroiliac joint injections for symptomatic relief of sacroiliac joint pain [16] .
EVIDENCE SUMMARY (Table 3) The overall strength of evidence is very low for outcomes common to the two treatments (surgical and injection) and is based on lack of comparative studies and small sample sizes. Determination of effect sizes for differences between surgical and injection treatment is not possible and further comparative research is needed. Table 3 Compare pain, functionality, quality of life, and return to work for surgical vs injection treatment of injection-confirmed sacroiliac joint pain. Only one injection study reported complications (flu-like symptoms in the Botulinum toxin arm of the study)
• An occupational medicine practice guideline recommended sacroiliac joint corticosteroid injections for acute, low back pain, known sacroiliitis, spinal fractures, radicular pain syndrome, and low back pain believed to be due to the sacroiliac joint [17] .
• A European Cooperation in Science and Technology (COST) guideline for the management of chronic nonspecific low back pain [18] did not recommend sacroiliac joint corticosteroid injections due to limited evidence.
• The American Society of Interventional Pain Physicians' guidelines [19] for the management of chronic spinal pain found limited evidence for the use of intraarticular sacroiliac joint injections in short-term and long-term sacroiliac joint pain relief and described moderate evidence for sacroiliac joint blocks to diagnose sacroiliac joint pain. 
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ILLUSTRATIVE CASE
The patient is a 37-year-old retired professional cyclist with 8 years' status post L4-S1 fusion for recurrent disc herniations, and 3 years' status post L3-4 fusion for adjacent segment degeneration (Figs 4 and 5) . Each of these surgeries was successful in relieving her preoperative pain. One year after L3-4 interbody fusion, she began experiencing increasing left, low back and buttock pain consistent on examination with pain emanating from her sacroiliac joint. Her symptoms were initially relieved with physical therapy directed at her left sacroiliac joint, and later a sacroiliac joint belt, which helped for a brief period. With recurrent symptoms, she underwent a series of guided sacroiliac corticosteroid injections that each significantly relieved her pain. Eventually, she failed to respond to further injections, therapy, or oral medications and elected to undergo a mini-open sacroiliac joint fusion (Fig 6) , with placement of percutaneous sacroiliac screws and an iliac bolt connected to her posterior instrumentation (Figs 7 and 8 ). Postoperatively, she noted immediate and remarkable pain relief, and 1 year after sacroiliac joint fusion she is virtually pain free and has returned to full and unrestricted activity.
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DISCUSSION
• This systematic review is limited by the following: -The existing literature reporting outcomes on surgical treatment of CSJP is limited to case series. No studies were identified that compared surgical with injection treatment in the same patient population, so conclusions regarding the comparative effectiveness of the treatments are not possible. -Most studies comprised small sample sizes and reported short follow-up time, bringing into question the duration of treatment effect. The study population included a mixture of diagnoses and many patients who had undergone previous spinal surgery, making direct comparisons of the interventions difficult to interpret. -There was heterogeneity with respect to procedural details in the injection studies, including the type of injectant and number of injections. These differences must be considered when interpreting the findings of this systematic review. -Fusion results should be interpreted with caution, as two of the five studies that provide the basis for the fusion results used plain radiographs only (of limited value in confirming fusion), while only a single study used CT scans in all patients to determine fusion.
• All studies reported pain relief regardless of the intervention. The amount and duration of pain relief was highly variable and difficult to compare.
• Complication and infection rates are likely higher with surgical intervention than with therapeutic injections as suggested by this review.
• The data suggests similar outcomes in patients treated with surgical fusion and those treated with therapeutic injections, with increased complications reported in surgical patients. Thus, surgical intervention should likely be reserved for patients who have failed nonoperative treatment modalities. • There is a need for a well-designed comparative study to evaluate the effectiveness of the current treatment modalities used for CSJP. 
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EDITORIAL PERSPECTIVE
